{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":277,"total_is_capped":false,"direct_labels_cover":1,"predictions_cover":277,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"3c87b132f7a2","filters":{"topic":"Multiple and Secondary Primary Cancers"}},"results":[{"id":"W2130803751","doi":"10.1093/jnci/dji278","title":"Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors","year":2005,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":830,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Cancer Care Ontario","funders":"National Institutes of Health","keywords":"Medicine; Relative risk; Cancer; Relative survival; Internal medicine; Poisson regression; Confidence interval; Population; Cohort; Testicular cancer; Absolute risk reduction; Lung cancer; Bladder cancer; Gastroenterology; Cancer registry","retraction":null,"screen_n_in":null,"score":{"opus":0.03050255096056219,"gpt":0.3127907066982983,"spread":0.2822881557377361,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003231476,0.000267685,0.0004348913,0.0002370629,0.0002166463,0.00004029567,0.000383347,0.000122722,0.001748723],"category_scores_gemma":[0.0002408161,0.0001831308,0.000338436,0.0003444343,0.0002397251,0.0006526638,0.00005187004,0.0006804363,0.00001120486],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004388336,"about_ca_system_score_gemma":0.002907298,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005814044,"about_ca_topic_score_gemma":0.009830587,"domain_scores_codex":[0.9972144,0.00005574216,0.0007048925,0.0002558214,0.001452773,0.0003163379],"domain_scores_gemma":[0.9975995,0.00008852355,0.0007065805,0.0001863541,0.001171448,0.0002475919],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00223063,0.0004731867,0.8390471,0.0002144647,0.001272392,0.00005981501,0.000622003,0.04533413,0.001547816,0.0002415534,0.05168617,0.05727069],"study_design_scores_gemma":[0.00487028,0.0002536379,0.9140339,0.0006663614,0.000235623,0.00005228678,0.00001010311,0.000282857,0.005215017,0.00008134562,0.07401755,0.0002810172],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9837446,0.001350376,0.0000212678,0.004122189,0.004143531,0.000385357,0.0002319115,0.00001541517,0.005985361],"genre_scores_gemma":[0.9880551,0.0005773309,0.0001200302,0.006339242,0.003187558,0.00003853767,0.00001443784,0.000031735,0.001636036],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07498677,"threshold_uncertainty_score":0.9994336,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2098179714","doi":"10.1200/jco.2002.09.038","title":"Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 Years","year":2002,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":564,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Population; Relative risk; Cancer; Confidence interval; Internal medicine; Breast cancer; Thyroid; Esophagus; Gastroenterology","retraction":null,"screen_n_in":null,"score":{"opus":0.1041979587493725,"gpt":0.4418720165728018,"spread":0.3376740578234293,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002793071,0.0001352414,0.001113341,0.0001977184,0.00002659162,0.000007684517,0.0001393871,0.000276362,0.01029477],"category_scores_gemma":[0.001834427,0.0001093052,0.0005748204,0.0001384213,0.0001508935,0.0001700407,0.00002148674,0.0005464093,0.00001201803],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002825342,"about_ca_system_score_gemma":0.001228443,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006301063,"about_ca_topic_score_gemma":0.00047881,"domain_scores_codex":[0.9961503,0.0005583005,0.002190019,0.0002047921,0.0006963238,0.0002002891],"domain_scores_gemma":[0.9955381,0.001418055,0.001929187,0.0002570129,0.0004046723,0.0004530341],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001501962,0.0007052633,0.9199517,0.00007803504,0.0001988608,0.0002908845,0.00005762375,0.0002427868,0.00005960155,0.000008614366,0.001662795,0.07524191],"study_design_scores_gemma":[0.008544686,0.002319414,0.9799295,0.0001483076,0.0004876432,0.00002394586,0.00001153832,0.005879892,0.00002095774,0.00004056767,0.002491769,0.0001017929],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959225,0.0006059741,0.00005397876,0.0007040252,0.00131387,0.0003100373,0.00001709913,0.000006690946,0.001065828],"genre_scores_gemma":[0.9969702,0.0001706721,0.0004126281,0.001468986,0.0005562493,0.000004844732,0.00002644686,0.00001857768,0.000371445],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07514012,"threshold_uncertainty_score":0.9906099,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2729284305","doi":"10.1016/s1470-2045(17)30445-x","title":"Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study","year":2017,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":503,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Consumers, Health, Agriculture and Food Executive Agency; Queen's University; Queen's University Belfast; European Commission","keywords":"Relative survival; Medicine; Incidence (geometry); European union; Cancer registry; Population; Demography; Cancer; Referral; Pediatrics; Internal medicine; Family medicine; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.0724263099790792,"gpt":0.3657372715329165,"spread":0.2933109615538373,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000306416,0.00008738053,0.0005477918,0.00004656929,0.00005105717,0.000005100866,0.0001449536,0.00004214773,0.00003107898],"category_scores_gemma":[0.000200097,0.00005579195,0.00002764604,0.00004894125,0.00008077618,0.00002958531,0.00003128251,0.00007820893,7.180366e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001179823,"about_ca_system_score_gemma":0.0002454077,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004094271,"about_ca_topic_score_gemma":0.002051037,"domain_scores_codex":[0.999133,0.0001891865,0.0002878957,0.0001544832,0.00009068408,0.0001447678],"domain_scores_gemma":[0.9989274,0.0001763255,0.0002648558,0.0005307378,0.00006310459,0.00003759644],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005510237,0.0002520128,0.9682473,0.00005506144,0.0000639691,0.00007478969,0.002971326,0.0001816814,0.0009735845,0.00001957775,0.0002483714,0.0214021],"study_design_scores_gemma":[0.0189217,0.001943299,0.9737187,0.00004453185,0.00007347947,0.000003275866,0.0003591605,0.0002424694,0.0005789229,0.00001018449,0.004056111,0.00004814859],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990731,0.0001503643,5.4822e-7,0.004363453,0.00009086487,0.0005975182,0.00007495455,0.00000726497,0.003984013],"genre_scores_gemma":[0.9992575,0.00009045323,0.0001055965,0.000143637,0.0001734174,0.00001557507,0.00005496461,0.000007560568,0.0001512935],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02135395,"threshold_uncertainty_score":0.618934,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2033297297","doi":"10.1089/thy.2008.0392","title":"Second Primary Malignancy Risk After Radioactive Iodine Treatment for Thyroid Cancer: A Systematic Review and Meta-analysis","year":2009,"lang":"en","type":"review","venue":"Thyroid","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":349,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Occupational Cancer Research Centre; Mount Sinai Hospital; St. Joseph’s Healthcare Hamilton; Ontario Institute for Cancer Research; McMaster University; University of Toronto; University Health Network","funders":"University of Toronto; University Health Network; Canadian Institutes of Health Research; American Thyroid Association","keywords":"Medicine; Thyroid cancer; Relative risk; Meta-analysis; Confidence interval; Internal medicine; Cancer; Oncology; Thyroid; Incidence (geometry)","retraction":null,"screen_n_in":null,"score":{"opus":0.06571723558180188,"gpt":0.3507970186731116,"spread":0.2850797830913097,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0006797058,0.001334646,0.02062479,0.0005226008,0.0001369933,0.00005517056,0.0002497467,0.000357227,0.002091076],"category_scores_gemma":[0.00006835382,0.0008022886,0.007176957,0.0007227105,0.0000907448,0.0001521867,0.00005311771,0.0004251521,0.00003183341],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001380275,"about_ca_system_score_gemma":0.0008450394,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000725401,"about_ca_topic_score_gemma":0.0001164452,"domain_scores_codex":[0.9952589,0.0005468956,0.001917207,0.001280268,0.0003868626,0.0006099194],"domain_scores_gemma":[0.9958788,0.0004962747,0.001590058,0.001479112,0.0001723735,0.00038341],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00009795305,0.0001075029,9.886297e-7,0.6978871,0.276498,0.00005496656,0.00008543889,1.856228e-7,5.628477e-7,0.000003376817,0.001864063,0.02339993],"study_design_scores_gemma":[0.0009999988,0.0006458001,0.000005065396,0.0200992,0.7486445,0.0001057095,0.000005947562,0.000002652798,0.000001646342,0.000006729872,0.228938,0.0005447309],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000002745279,0.9775884,0.00004567091,0.0002083226,0.00005161341,0.01427642,0.006759198,0.00007014011,0.0009975275],"genre_scores_gemma":[0.000003712644,0.9715669,0.0007619103,0.00276116,0.0001545664,0.01224483,0.001264104,0.0001148167,0.01112804],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6777879,"threshold_uncertainty_score":0.9999405,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1989412643","doi":"10.1200/jco.2012.41.8681","title":"Second Malignant Neoplasms: Assessment and Strategies for Risk Reduction","year":2012,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":336,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Cancer; Epidemiology; Oncology; Host factors; Family history; Internal medicine; Bioinformatics; Immunology; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.3038633936729731,"gpt":0.5563747030338985,"spread":0.2525113093609254,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005138112,0.0002775766,0.005044173,0.0001785876,0.00005886611,0.00002259778,0.0001276379,0.0009685587,0.0004872571],"category_scores_gemma":[0.0004105768,0.0001757026,0.001346685,0.00006872534,0.0001997802,0.0002329501,0.00004147059,0.001935092,0.00000499412],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003916966,"about_ca_system_score_gemma":0.01133064,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004715134,"about_ca_topic_score_gemma":0.00001446835,"domain_scores_codex":[0.9949752,0.0006697773,0.003600767,0.0002571165,0.0002193442,0.0002777727],"domain_scores_gemma":[0.991175,0.00276278,0.005117806,0.0002061827,0.0002785086,0.0004597378],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004766604,0.0003050001,0.0001032269,0.005232361,0.001142484,0.0000509311,0.00003321903,3.687645e-7,7.662283e-7,0.0001506114,0.004935592,0.9875688],"study_design_scores_gemma":[0.003213606,0.007406436,0.0007235821,0.00171323,0.00708425,0.002225083,0.0001693453,0.000006630934,2.018353e-7,0.0002233398,0.9770795,0.0001547636],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009818523,0.9898956,0.000272381,0.0002434278,0.0042848,0.0007210982,0.00005815156,0.00000665413,0.003535991],"genre_scores_gemma":[0.0002347304,0.9853175,0.0090687,0.0002547007,0.004554982,0.00002535603,0.00002499208,0.00003478232,0.000484256],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.987414,"threshold_uncertainty_score":0.9942742,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3035865887","doi":"10.1016/j.canep.2020.101760","title":"Epidemiology of liver metastases","year":2020,"lang":"es","type":"article","venue":"Cancer Epidemiology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":277,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Penn State Hershey Cancer Institute; International Association for the Study of Lung Cancer; National Institutes of Health; American Cancer Society","keywords":"Medicine; Metastasis; Epidemiology; Internal medicine; Oncology; Incidence (geometry); Prostate; Cancer; Gastroenterology; Population; Breast cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.1987757871004025,"gpt":0.4049519550317286,"spread":0.2061761679313261,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002718687,0.0005743838,0.004186155,0.0001495943,0.00008446626,0.000001128791,0.0004774936,0.0006199352,0.009529464],"category_scores_gemma":[0.01248456,0.0004991987,0.0007274374,0.0003330963,0.001307223,0.0001256133,0.0002388252,0.0009108253,0.0003778627],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002458657,"about_ca_system_score_gemma":0.0009731512,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001973676,"about_ca_topic_score_gemma":0.00003829673,"domain_scores_codex":[0.991866,0.00323006,0.002396257,0.001176326,0.0001320759,0.001199294],"domain_scores_gemma":[0.9872923,0.009580677,0.001326147,0.0006844719,0.0002252806,0.0008910971],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001559252,0.0000860435,0.8354927,0.002862297,0.001428453,0.00007962836,0.0004892508,0.0008921287,0.0009628322,0.01439156,0.1089082,0.03284762],"study_design_scores_gemma":[0.003441418,0.002093914,0.4181174,0.0005483007,0.0016052,0.00003361947,0.0001774379,0.01000997,0.001254387,0.0007777233,0.5612551,0.0006854906],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.09749539,0.77614,0.00506988,0.1121245,0.002908265,0.001349081,0.002070272,0.0001533194,0.002689295],"genre_scores_gemma":[0.7891029,0.06808261,0.004406256,0.1340131,0.003440064,0.0001309944,0.0002866599,0.00009296074,0.0004445039],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.7080573,"threshold_uncertainty_score":0.999746,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2294907556","doi":"10.1136/bmj.i851","title":"Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis","year":2016,"lang":"en","type":"review","venue":"BMJ","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":274,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Mount Sinai Hospital; Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Meta-analysis; Internal medicine; Odds ratio; Hazard ratio; Oncology; Radiation therapy; Prostate cancer; Confidence interval; Cancer; Prostate","retraction":null,"screen_n_in":null,"score":{"opus":0.07404702402521818,"gpt":0.3897819200618978,"spread":0.3157348960366796,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008557558,0.0005549177,0.01232219,0.0002384381,0.00004383728,0.00003314534,0.0001395548,0.0001719147,0.006396039],"category_scores_gemma":[0.00007376087,0.0002781528,0.003760833,0.0002957227,0.000064045,0.00007931593,0.00002687154,0.0001346188,0.00001633119],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002221172,"about_ca_system_score_gemma":0.0005217318,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008436197,"about_ca_topic_score_gemma":0.00003645404,"domain_scores_codex":[0.9972618,0.0002226307,0.001388521,0.0005875691,0.0002251778,0.0003142993],"domain_scores_gemma":[0.9977226,0.0002807671,0.0008677085,0.000835574,0.0001357007,0.0001576427],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001564719,0.000006405986,8.006485e-7,0.780889,0.1979433,0.00001229055,0.00002641865,1.029836e-8,1.127499e-7,0.000003640658,0.008856227,0.01224618],"study_design_scores_gemma":[0.0001720625,0.00003371513,5.377958e-7,0.05259656,0.4604596,0.00003447888,0.000001230545,4.517633e-7,1.591386e-7,0.000001192129,0.4865184,0.0001815726],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[1.689491e-7,0.9814641,0.00004490321,0.001248776,0.00006614417,0.01477634,0.002198019,0.00002715645,0.0001744344],"genre_scores_gemma":[2.182694e-7,0.9332352,0.0003956423,0.00484211,0.0001309829,0.02197117,0.0001141453,0.00007079848,0.03923974],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7282924,"threshold_uncertainty_score":0.999967,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2791567841","doi":"10.5858/2002-126-384a-pfic","title":"Prognostic Factors in Cancer","year":2002,"lang":"en","type":"article","venue":"Archives of Pathology & Laboratory Medicine","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":187,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Compendium; Cancer; Disease; Relevance (law); Medicine; Pathology; History; Internal medicine; Political science","retraction":null,"screen_n_in":null,"score":{"opus":0.03233255746807569,"gpt":0.2958710224801955,"spread":0.2635384650121198,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001297363,0.0001840572,0.0005967842,0.0003559889,0.00002940842,9.704314e-7,0.0001191813,0.00008344103,0.001853023],"category_scores_gemma":[0.0003490679,0.000139305,0.00005183968,0.0003414753,0.0007832189,0.00005801786,0.00003116242,0.0003230248,0.000008043772],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004157532,"about_ca_system_score_gemma":0.0001342677,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007508256,"about_ca_topic_score_gemma":0.00009359168,"domain_scores_codex":[0.9986579,0.0001219258,0.0004355877,0.0003097691,0.0001745459,0.000300248],"domain_scores_gemma":[0.9989999,0.0003559895,0.0001298447,0.000310605,0.00004873426,0.000154935],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001271693,0.0001994102,0.8758211,0.000206441,0.00004952327,0.0007009823,0.007028141,0.000007359534,0.1056931,0.0001416071,0.001227332,0.008797762],"study_design_scores_gemma":[0.004103923,0.001036562,0.9799569,0.0004553617,0.0001200862,0.00004205903,0.0008180615,0.0002810205,0.004549924,0.00009691068,0.008367847,0.0001713647],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9832341,0.006145844,0.00002403609,0.001952667,0.0002796425,0.0003267321,0.00004644063,0.00003556667,0.007954989],"genre_scores_gemma":[0.9960836,0.001598083,0.0002949396,0.001427561,0.0001477426,0.00003511667,0.00002870149,0.00002209043,0.0003622156],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1041357,"threshold_uncertainty_score":0.9990594,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2057985610","doi":"10.1158/1078-0432.ccr-10-2224","title":"The Ability to Form Primary Tumor Xenografts Is Predictive of Increased Risk of Disease Recurrence in Early-Stage Non–Small Cell Lung Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Histology; Primary tumor; Lung cancer; Pathology; Cancer; Epidermal growth factor receptor; Oncology; Stage (stratigraphy); Cancer research; Internal medicine; Metastasis; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.06839996388077083,"gpt":0.4448765100299225,"spread":0.3764765461491517,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005746442,0.0002111546,0.0007069783,0.0001938549,0.000158697,0.00002093368,0.0006470769,0.0001580452,0.0005820271],"category_scores_gemma":[0.002617608,0.000151584,0.0002879862,0.0007938338,0.001151857,0.0001175047,0.0003765158,0.002402806,0.000006112254],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000405693,"about_ca_system_score_gemma":0.005056588,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01794973,"about_ca_topic_score_gemma":0.00569406,"domain_scores_codex":[0.9958238,0.0005265569,0.001188195,0.0007329353,0.001018268,0.0007102272],"domain_scores_gemma":[0.9938049,0.002903268,0.0003080351,0.001183717,0.0009519446,0.000848187],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01230408,0.0004958214,0.9650639,0.001017795,0.00006633766,0.0000147084,0.0008854443,0.00001582723,0.00263256,0.000005512387,0.002619132,0.01487886],"study_design_scores_gemma":[0.003082049,0.0008528121,0.9858888,0.0003361618,0.00008867103,1.74903e-7,0.000124477,0.001194729,0.003618018,0.00005752889,0.004608835,0.0001476833],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921916,0.001244368,0.00001533608,0.000914095,0.0004801776,0.002523171,0.001257896,0.00001337898,0.001359969],"genre_scores_gemma":[0.9947129,0.003132155,0.0001860634,0.0005020334,0.0003502915,0.0006972821,0.00001525727,0.00003127178,0.0003726899],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02082494,"threshold_uncertainty_score":0.9998987,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2051415992","doi":"10.1089/thy.2007.0171","title":"Second Primary Malignancy Risk in Thyroid Cancer Survivors: A Systematic Review and Meta-Analysis","year":2007,"lang":"en","type":"review","venue":"Thyroid","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Occupational Cancer Research Centre; Mount Sinai Hospital; St. Joseph’s Healthcare Hamilton; Ontario Institute for Cancer Research; McMaster University; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Thyroid cancer; Meta-analysis; Malignancy; Oncology; Cancer; Internal medicine; Thyroid","retraction":null,"screen_n_in":null,"score":{"opus":0.08179582737510323,"gpt":0.363010182609424,"spread":0.2812143552343208,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002846019,0.001137651,0.02022865,0.001148103,0.00008510682,0.00004709503,0.0004200501,0.0004994502,0.004449745],"category_scores_gemma":[0.0001687726,0.0007568133,0.004140431,0.002164379,0.0001199551,0.0001712707,0.0001627612,0.001227348,0.00008829898],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006860344,"about_ca_system_score_gemma":0.000786755,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009428051,"about_ca_topic_score_gemma":0.003669825,"domain_scores_codex":[0.9935707,0.001009318,0.00284603,0.001219367,0.0006388703,0.0007156547],"domain_scores_gemma":[0.9955181,0.0006667417,0.00165196,0.001662123,0.0001397688,0.0003613298],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00001270491,0.00005588084,0.00001370992,0.8793725,0.1128738,0.0001370014,0.00007227438,2.899671e-7,4.020604e-7,0.000007108945,0.0008647323,0.006589579],"study_design_scores_gemma":[0.00038499,0.00007981918,0.00002231625,0.04708982,0.7683982,0.0001022373,0.00001061505,0.00000183536,3.985346e-7,0.000004515794,0.1833071,0.0005981084],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00000929601,0.9876868,0.00001551437,0.00007780746,0.00007303611,0.006341413,0.001063963,0.000066591,0.004665563],"genre_scores_gemma":[0.000004138881,0.9866636,0.000191525,0.003155047,0.0000880458,0.001531713,0.0005283667,0.0001265281,0.007711077],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8322827,"threshold_uncertainty_score":0.9994883,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3136330176","doi":"10.1016/j.jtho.2021.02.024","title":"Tobacco Smoking and Risk of Second Primary Lung Cancer","year":2021,"lang":"en","type":"review","venue":"Journal of Thoracic Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; Pharmacyclics; Centers for Disease Control and Prevention; Clovis Oncology; National Institutes of Health; Helsinn; ACEA Biosciences; Pfizer; Daiichi Sankyo Europe; World Health Organization; Exelixis; Centre International de Recherche sur le Cancer; Celgene; Myriad Genetics; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Lung cancer; Primary (astronomy); Environmental health; Oncology; Primary cancer; Internal medicine; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.04318808723122156,"gpt":0.4503426521901326,"spread":0.407154564958911,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001190855,0.0003295233,0.00448307,0.0004097253,0.00005072856,0.00001396155,0.0001945232,0.0005926443,0.001670507],"category_scores_gemma":[0.0001838959,0.0002450747,0.0008269787,0.0002491622,0.0001330402,0.0001281795,0.0001293121,0.001687984,7.611102e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001213422,"about_ca_system_score_gemma":0.006047349,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002593469,"about_ca_topic_score_gemma":0.00005934047,"domain_scores_codex":[0.997057,0.0005639415,0.001566129,0.0002736968,0.0002754322,0.0002638353],"domain_scores_gemma":[0.9953997,0.0006357317,0.003089126,0.0002882013,0.0003547152,0.0002324835],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001961317,0.0000850682,0.001753596,0.02232565,0.002860884,0.0006269406,0.0001292533,0.000001009825,0.000008455007,0.000002803664,0.005414223,0.966596],"study_design_scores_gemma":[0.000611843,0.000510986,0.000860807,0.0166596,0.01189055,0.003274695,0.00006421992,0.000002339573,0.00001023651,0.000004606853,0.9659256,0.0001844592],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.007546848,0.9873917,0.0000144176,0.0001099715,0.001363887,0.000338194,0.0001051021,0.000005015152,0.003124899],"genre_scores_gemma":[0.00005533047,0.9963607,0.001450349,0.0003270555,0.0009356198,0.00001134559,0.00002753646,0.00004604192,0.0007860623],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9664115,"threshold_uncertainty_score":0.9995874,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2080190730","doi":"10.1002/cncr.23315","title":"Dying with cancer","year":2008,"lang":"en","type":"article","venue":"Cancer","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"","keywords":"Medicine; Comorbidity; Cancer; Disease; Population; Cause of death; Cancer registry; Proportional hazards model; Hazard ratio; Internal medicine; Oncology; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.04464850568565971,"gpt":0.3009720211619447,"spread":0.256323515476285,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00002224266,0.0001050454,0.0001929838,0.00003998567,0.00009415913,0.000003893584,0.00004659944,0.00003989275,0.004253631],"category_scores_gemma":[0.000003678595,0.0000770325,0.00003759639,0.0001286699,0.0000910861,0.00008043586,0.00001091769,0.0001402483,0.00002318685],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002381223,"about_ca_system_score_gemma":0.0006514819,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000567253,"about_ca_topic_score_gemma":0.0001345041,"domain_scores_codex":[0.9993237,0.000006435016,0.00009917541,0.0001981352,0.0001632133,0.0002093959],"domain_scores_gemma":[0.9995899,0.00001153164,0.00003599239,0.0001759182,0.00006616116,0.0001204946],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001317225,0.0000744014,0.774631,0.0002447551,0.0003879489,0.0005704801,0.002224987,0.0003303325,0.01742406,0.00002870579,0.08628558,0.1164805],"study_design_scores_gemma":[0.006117397,0.0002968139,0.3931658,0.0003656008,0.0001795557,0.0004299925,0.0001365553,0.0002992792,0.02527335,0.000006228158,0.5732631,0.0004663368],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9707522,0.005476549,0.00007937643,0.001402365,0.0002701753,0.0001968132,0.00001445298,0.00006796169,0.02174009],"genre_scores_gemma":[0.9788232,0.003239378,0.0004013941,0.005945474,0.0004676547,0.0001515525,0.00001058253,0.00002954449,0.01093122],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4869775,"threshold_uncertainty_score":0.9966566,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2085673437","doi":"10.1007/s11764-013-0278-6","title":"Screening for new primary cancers in cancer survivors compared to non-cancer controls: a systematic review and meta-analysis","year":2013,"lang":"en","type":"review","venue":"Journal of Cancer Survivorship","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Cancer Care Nova Scotia; Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cancer; Prostate cancer; Breast cancer; Oncology; Meta-analysis; Colorectal cancer; Cervical cancer; Internal medicine; Cancer screening; Epidemiology of cancer; Survivorship curve; Odds ratio; Gynecology","retraction":null,"screen_n_in":null,"score":{"opus":0.2051941523925334,"gpt":0.4218015501701301,"spread":0.2166073977775967,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.003022311,0.001317785,0.02552878,0.001717198,0.0001024013,0.0001401408,0.0008061656,0.0004457674,0.00176841],"category_scores_gemma":[0.0003196518,0.0008896639,0.00559238,0.002361858,0.0000939611,0.0004170941,0.0001126725,0.001230438,0.000004505151],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002672163,"about_ca_system_score_gemma":0.00558842,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.08325578,"about_ca_topic_score_gemma":0.1140495,"domain_scores_codex":[0.9914681,0.0007977794,0.004692411,0.0009456006,0.001146544,0.0009495745],"domain_scores_gemma":[0.9911932,0.001418689,0.004483846,0.000865881,0.0008913566,0.001146999],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0002913928,0.00004688895,0.0003505482,0.760749,0.2054096,0.00002928913,0.0002666965,0.0003071088,0.000001433704,0.000002602941,0.004021756,0.02852367],"study_design_scores_gemma":[0.001648247,0.0001858624,0.0001262958,0.1363029,0.7361318,0.00003383728,0.0000547943,0.00006123707,0.000001075056,0.000003782511,0.12466,0.0007901316],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004206808,0.9852952,0.0008185977,0.001946425,0.0005899466,0.0104715,0.0007164839,0.00001949083,0.0001002733],"genre_scores_gemma":[0.00004589169,0.9828303,0.001149629,0.006622468,0.0006166511,0.00553563,0.00006011893,0.0001792922,0.002959959],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6244461,"threshold_uncertainty_score":0.9999574,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2037321725","doi":"10.1097/01.coc.0000258084.55036.9e","title":"A Population-Based Analysis of Second Primary Cancers After Irradiation for Rectal Cancer","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Hazard ratio; Proportional hazards model; Cancer registry; Prostate cancer; Population; Cancer; Internal medicine; Incidence (geometry); Colorectal cancer; Cohort; Confidence interval; Oncology; Prostate; Epidemiology; Gynecology; Urology","retraction":null,"screen_n_in":null,"score":{"opus":0.04742313306440697,"gpt":0.4510760298879687,"spread":0.4036528968235618,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002201164,0.0001239825,0.001825041,0.0004982207,0.0000243835,0.000003073538,0.0001010422,0.00013421,0.0007568774],"category_scores_gemma":[0.0005426913,0.0001028138,0.0009049784,0.000650254,0.0002649945,0.00008230577,0.000009040243,0.0003560922,4.967611e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000887296,"about_ca_system_score_gemma":0.003123159,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000566102,"about_ca_topic_score_gemma":0.002734137,"domain_scores_codex":[0.9970828,0.000158072,0.002053146,0.0001984656,0.0002690071,0.0002384623],"domain_scores_gemma":[0.9940299,0.002667019,0.002379244,0.0001654598,0.0004674894,0.0002908281],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01332317,0.0001661645,0.6043904,0.00003543164,0.00182973,0.00002887659,0.0001055578,0.0006598497,0.0002097739,0.000003775946,0.0003693389,0.378878],"study_design_scores_gemma":[0.003719097,0.005573796,0.9677724,0.00003254752,0.002442061,0.000008783766,0.0001117172,0.0008831611,0.00005166525,0.000009489918,0.0192974,0.00009785828],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948097,0.000323449,0.002019754,0.001150794,0.0006614293,0.0002105819,0.00006635054,0.000005341832,0.000752611],"genre_scores_gemma":[0.9810541,0.000122944,0.009892513,0.008178901,0.0006018479,0.0000121818,0.00004246263,0.00001571801,0.00007938277],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3787801,"threshold_uncertainty_score":0.8287276,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2026506094","doi":"10.1016/j.ejcsup.2014.05.001","title":"Current knowledge and future research directions in treatment-related second primary malignancies","year":2014,"lang":"en","type":"article","venue":"European Journal of Cancer Supplements","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Cancer; Psychological intervention; Population; Radiation therapy; Survivorship curve; Biobank; Intensive care medicine; Oncology; Bioinformatics; Internal medicine; Environmental health; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.03951442861931224,"gpt":0.3603125424734014,"spread":0.3207981138540891,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001195678,0.0001564884,0.0003565909,0.0004172073,0.0001100053,0.00002850326,0.0001120036,0.00002350616,0.001746374],"category_scores_gemma":[0.00002030614,0.0001212459,0.00009049882,0.0002826378,0.00008759011,0.0001644383,0.00005344488,0.000437168,0.00001580281],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000507388,"about_ca_system_score_gemma":0.0003701086,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002117734,"about_ca_topic_score_gemma":0.0002062831,"domain_scores_codex":[0.9980478,0.0005845958,0.0005680649,0.0002026944,0.0002839595,0.0003128769],"domain_scores_gemma":[0.9991626,0.00007018927,0.0001693315,0.000167962,0.0002158997,0.0002140654],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004391534,0.0003234413,0.1038881,0.0001884205,0.0002157335,0.0001161753,0.003152451,0.000001808361,0.002536676,0.000047204,0.02278974,0.8663011],"study_design_scores_gemma":[0.00506647,0.0007362203,0.2530198,0.0002020072,0.000045858,0.00005096768,0.0001517436,0.000009721617,0.0003676789,0.00001149138,0.7402589,0.00007920717],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8937694,0.07433408,0.000007836166,0.001350237,0.001512652,0.0003349631,0.00006175693,0.00001249116,0.02861655],"genre_scores_gemma":[0.9286117,0.06579451,0.000310361,0.0002436825,0.002058479,0.00001592245,0.00005135228,0.00006320523,0.00285076],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8662219,"threshold_uncertainty_score":0.9991662,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2623364824","doi":"10.1097/cej.0000000000000372","title":"Survival of solid cancer patients in France, 1989–2013: a population-based study","year":2017,"lang":"en","type":"article","venue":"European Journal of Cancer Prevention","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Medicine; Cancer; Lung cancer; Mesothelioma; Internal medicine; Population; Thyroid cancer; Prostate cancer; Cancer registry; Oncology; Pathology; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.02775282059583982,"gpt":0.3410724843827274,"spread":0.3133196637868876,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008205455,0.0001284696,0.0004324269,0.0001835118,0.000087212,0.00001983041,0.0002270671,0.00002188352,0.0003553814],"category_scores_gemma":[0.00008100933,0.0001116241,0.0001680457,0.00007970011,0.00003153494,0.0002778609,0.0000312389,0.0002337153,0.000002375828],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001695076,"about_ca_system_score_gemma":0.000285288,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007176935,"about_ca_topic_score_gemma":0.0009878677,"domain_scores_codex":[0.9981687,0.0002960561,0.0007828272,0.0001544281,0.0004452901,0.0001526978],"domain_scores_gemma":[0.9980122,0.0000204165,0.001282192,0.000282774,0.0003105923,0.00009180629],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004609274,0.0005352446,0.9585609,0.00007938098,0.0001081828,0.00003036045,0.0002501426,0.0007723102,0.0003332499,7.748841e-7,0.000185117,0.03868335],"study_design_scores_gemma":[0.008905508,0.0009308321,0.9876322,0.0006676497,0.0001224372,7.979116e-7,0.00004602196,0.0001257542,0.0002119155,0.000007062757,0.00125326,0.0000965555],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970454,0.0004900254,0.0001124592,0.0001905163,0.001051147,0.0003715813,0.00002565272,0.000004526254,0.0007086887],"genre_scores_gemma":[0.998803,0.0002047198,0.0001042771,0.00007930254,0.0003067072,0.000005827488,0.000008618897,0.00002625426,0.0004613487],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0385868,"threshold_uncertainty_score":0.4551898,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2047213739","doi":"10.1097/01.jto.0000263708.08332.76","title":"Does Intensive Follow-up Alter Outcome in Patients with Advanced Lung Cancer?","year":2007,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Lung cancer; Clinical trial; Asymptomatic; Stage (stratigraphy); Randomized controlled trial; Cancer; Internal medicine; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.01643377423926782,"gpt":0.4023726481106881,"spread":0.3859388738714203,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005586054,0.0001562546,0.0007313498,0.0003281934,0.00003076516,0.000005635215,0.000120112,0.0001297739,0.0002583585],"category_scores_gemma":[0.0001835718,0.00008340332,0.0001226305,0.0001851324,0.00007534411,0.000214815,0.00003058251,0.0006061543,0.000002424634],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001171133,"about_ca_system_score_gemma":0.0004959519,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003064456,"about_ca_topic_score_gemma":0.0003893141,"domain_scores_codex":[0.9983736,0.00006192904,0.0007739943,0.0001643877,0.0002935458,0.0003325632],"domain_scores_gemma":[0.9981523,0.0001564889,0.000593222,0.0001537163,0.0007459599,0.0001983101],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01857063,0.0001410146,0.7833887,0.00008217208,0.0001523756,0.0005149517,0.0007082212,0.00003283263,0.000414292,0.000002560633,0.0006832651,0.1953089],"study_design_scores_gemma":[0.009812409,0.003323992,0.9667764,0.0003172985,0.0002746079,0.00009470711,0.001034276,0.00003130978,0.001151754,0.00001748785,0.01699093,0.000174889],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935267,0.0003868965,0.000242078,0.002397719,0.002345313,0.0002974462,0.000006364978,0.000007266366,0.0007902277],"genre_scores_gemma":[0.9924207,0.00007469079,0.002325298,0.004138943,0.0002745766,0.000004090268,0.000005192124,0.00002107925,0.0007354449],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.195134,"threshold_uncertainty_score":0.3401089,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1534958170","doi":"10.1002/cncr.11824","title":"Cancer Medicine 6","year":2003,"lang":"en","type":"article","venue":"Cancer","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Index (typography); Alternative medicine; Cancer; Family medicine; Pathology; Internal medicine; Computer science; World Wide Web","retraction":null,"screen_n_in":null,"score":{"opus":0.04114090055147159,"gpt":0.3474002225502854,"spread":0.3062593219988138,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009484033,0.0001302062,0.0002785101,0.00006087083,0.00005439144,0.000003962098,0.00005319483,0.00006272506,0.03224787],"category_scores_gemma":[0.00005325528,0.00009854658,0.00005732326,0.0001786693,0.0001122211,0.00005863848,0.000007355598,0.0001601898,0.00004401814],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002718182,"about_ca_system_score_gemma":0.0004588892,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003900043,"about_ca_topic_score_gemma":0.0001020399,"domain_scores_codex":[0.9991256,0.00002128388,0.0001768347,0.0002376828,0.0001899476,0.0002486278],"domain_scores_gemma":[0.9994223,0.00002518999,0.00004705495,0.000238931,0.00008213901,0.0001843854],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003933946,0.00009393392,0.1607497,0.0003994358,0.0004459276,0.0001188677,0.001466454,0.00006415599,0.04479865,0.003738579,0.5076054,0.2801255],"study_design_scores_gemma":[0.002351096,0.00008857543,0.01646321,0.0001464334,0.0001049869,0.0000193525,0.0001002126,0.00002965068,0.008646653,0.00009645997,0.9718139,0.0001394249],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5234301,0.05499618,0.0001663826,0.01334092,0.003263071,0.0006362561,0.00003818907,0.0001682415,0.4039606],"genre_scores_gemma":[0.9383715,0.006983251,0.0002700708,0.0212939,0.001029892,0.0002321337,0.00001497765,0.00004589016,0.03175844],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4642085,"threshold_uncertainty_score":0.9686368,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2078040239","doi":"10.1503/cmaj.110167","title":"Associations between first and second primary cancers: a population-based study","year":2011,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false},"ca_institutions":"","funders":"Herlev Hospital; Gentofte Hospital; Kræftens Bekæmpelse","keywords":"Medicine; Cancer; Confidence interval; Absolute risk reduction; Hazard ratio; Population; Internal medicine; Cancer registry; Proportional hazards model; Demography; Oncology; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.02371045379970275,"gpt":0.2549450271606863,"spread":0.2312345733609836,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001272265,0.0001508914,0.0004228443,0.0002708659,0.0004544284,0.00005583716,0.0001197964,0.000300528,0.01261828],"category_scores_gemma":[0.0007523372,0.0001465447,0.00009602669,0.0002237381,0.00002265219,0.0001783763,0.00001241775,0.0008397019,0.0000274548],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.004556509,"about_ca_system_score_gemma":0.005949652,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.02335158,"about_ca_topic_score_gemma":0.2219233,"domain_scores_codex":[0.9976643,0.000137214,0.000561435,0.0002158397,0.0009925775,0.0004286491],"domain_scores_gemma":[0.9973434,0.0002297249,0.0002956169,0.0001281211,0.0002734628,0.001729655],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00001426406,0.00004296183,0.9799404,0.00001177318,0.0002351443,0.0001338387,0.000876647,7.77607e-7,5.811809e-7,0.000007427817,0.01018156,0.008554641],"study_design_scores_gemma":[0.002465261,0.0002002783,0.9705197,0.00004075625,0.0001272434,0.00002572511,0.0002790331,0.00005046737,0.000002159323,0.00003420792,0.02611034,0.0001448091],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9834466,0.0001484128,0.00002729705,0.004900239,0.0004125819,0.000383436,0.0002131987,0.00002940672,0.01043882],"genre_scores_gemma":[0.9873457,0.00001903396,0.0002358077,0.01075458,0.0009503965,0.00001197079,0.0001304529,0.00002237706,0.000529698],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1985717,"threshold_uncertainty_score":0.9996857,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2128439362","doi":"10.1023/a:1008356806417","title":"Second primary malignancies following the treatment of early stage ovarian cancer: Update of a study by the National Cancer Institute of Canada—Clinical Trials Group (NCIC—CTG)","year":2000,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Ontario Institute for Cancer Research; University of British Columbia; Thunder Bay Regional Health Sciences Centre","funders":"","keywords":"Medicine; Melphalan; Radiation therapy; Ovarian cancer; Cancer; Surgery; Stage (stratigraphy); Malignancy; Internal medicine; Uterine cancer; Oncology; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.1861734927056167,"gpt":0.4552554489166448,"spread":0.269081956211028,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002558036,0.0001899957,0.001478482,0.00006188427,0.00007893429,0.000003601003,0.0002574974,0.000117663,0.001940653],"category_scores_gemma":[0.0001581783,0.0001109343,0.0003705101,0.0001950825,0.0003522119,0.0001015864,0.00002872583,0.0001531066,4.589405e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002889937,"about_ca_system_score_gemma":0.006091258,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1750338,"about_ca_topic_score_gemma":0.2618761,"domain_scores_codex":[0.9967196,0.0006373301,0.001580304,0.0002642125,0.0005337406,0.0002648437],"domain_scores_gemma":[0.9975079,0.0009209498,0.0008784825,0.0003103869,0.0002909027,0.00009140003],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02023314,0.008344243,0.1646123,0.0005037258,0.01458828,0.000118926,0.0111389,0.0006076927,0.01956707,0.0004060004,0.1193969,0.6404829],"study_design_scores_gemma":[0.0113509,0.008971283,0.280878,0.00009309922,0.0006064928,0.000004887914,0.0006571904,0.00003049604,0.006692234,0.00003642668,0.690514,0.0001650029],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9852626,0.003377983,0.000002305727,0.004207308,0.0005086487,0.001175544,0.001266995,0.000004575857,0.004193985],"genre_scores_gemma":[0.9908573,0.003639961,0.00005443324,0.003095269,0.0001861155,0.0001525857,0.0000440919,0.00001460272,0.001955616],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6403179,"threshold_uncertainty_score":0.9995433,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1782486205","doi":"10.1186/1471-2407-5-48","title":"Minimum follow-up time required for the estimation of statistical cure of cancer patients: verification using data from 42 cancer sites in the SEER database","year":2005,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University; University of Saskatchewan","funders":"Magyar Tudományos Akadémia; Saskatchewan Cancer Agency","keywords":"Medicine; Surgical oncology; Cancer; Estimation; Covariate; Database; Oncology; Statistics; Internal medicine; Computer science; Mathematics","retraction":null,"screen_n_in":null,"score":{"opus":0.1033360771714553,"gpt":0.3830369991954882,"spread":0.2797009220240328,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003009967,0.0001500083,0.0003170224,0.00005461027,0.00006480509,0.00001289216,0.0003231009,0.00006783022,0.001261627],"category_scores_gemma":[0.0002296181,0.00009829969,0.00005229136,0.000190348,0.000124479,0.0003153531,0.00006031932,0.0001186634,0.00000283176],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002806017,"about_ca_system_score_gemma":0.0007528446,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009311425,"about_ca_topic_score_gemma":0.01030531,"domain_scores_codex":[0.9985382,0.0000697329,0.0004912202,0.000340968,0.0003624751,0.0001974332],"domain_scores_gemma":[0.998174,0.0005747342,0.0002864142,0.000750893,0.0001713434,0.00004264804],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.01276443,0.001205709,0.316111,0.002165662,0.001090447,0.000002406116,0.01031919,0.03260007,0.1366794,0.000208499,0.2139095,0.2729438],"study_design_scores_gemma":[0.006969105,0.0001012732,0.1387952,0.0005236663,0.0009407795,4.798915e-7,0.0003177387,0.829201,0.005421693,0.00003050718,0.0174587,0.0002398884],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9619994,0.005617581,0.007942436,0.001165447,0.0003658725,0.001507574,0.02133878,0.00001210164,0.0000508178],"genre_scores_gemma":[0.9817373,0.0008167604,0.01005156,0.0009419446,0.0004855709,0.0003500503,0.005391643,0.00003596826,0.000189263],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7966009,"threshold_uncertainty_score":0.9996514,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2009552685","doi":"10.1002/ijc.21284","title":"Associations between small intestine cancer and other primary cancers: An international population‐based study","year":2005,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Saskatchewan Cancer Agency; University of Manitoba; CancerCare Manitoba; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Cancer; Medicine; Internal medicine; Overdiagnosis; Gastroenterology; Rectum; Pancreatic cancer; Adenocarcinoma; Population; Small intestine; Pancreas; Incidence (geometry); Prostate cancer; Oncology; Large intestine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.05464943692917048,"gpt":0.3795908981906168,"spread":0.3249414612614463,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003561333,0.0001867955,0.0004096794,0.0003782156,0.00006053509,0.0000831966,0.0003462236,0.00007449942,0.001081449],"category_scores_gemma":[0.00009914592,0.000166449,0.0001143451,0.0001168113,0.00003672617,0.0005374916,0.00004833279,0.0003469505,0.000002697316],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002344534,"about_ca_system_score_gemma":0.0008306516,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002670504,"about_ca_topic_score_gemma":0.00328415,"domain_scores_codex":[0.9979854,0.0000539288,0.0007559896,0.000237435,0.0007902823,0.0001769645],"domain_scores_gemma":[0.9979855,0.0001114321,0.0006550806,0.0001412776,0.000906282,0.000200377],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003973688,0.000214188,0.8881673,0.000006430786,0.0009873833,0.00001794217,0.0005172199,0.001172704,0.0003236197,0.00001383659,0.0003407178,0.1078413],"study_design_scores_gemma":[0.004989539,0.0002699648,0.9708501,0.0001604041,0.0002923959,0.00001970949,0.0001017628,0.000671746,0.0002385235,0.00003218136,0.02220327,0.0001703808],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9903116,0.0007284731,0.0002098427,0.006065801,0.001192646,0.0002507,0.0004481015,0.00002479349,0.0007680695],"genre_scores_gemma":[0.9876636,0.000160257,0.002092429,0.005325295,0.004263522,0.00002536953,0.0001146111,0.000034706,0.00032024],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1076709,"threshold_uncertainty_score":0.9998317,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2590674004","doi":"10.1158/1055-9965.epi-16-0762-t","title":"Young Adult and Usual Adult Body Mass Index and Multiple Myeloma Risk: A Pooled Analysis in the International Multiple Myeloma Consortium (IMMC)","year":2017,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; World Health Organization; American Association for Cancer Research","keywords":"Multiple myeloma; Body mass index; Medicine; Internal medicine; Anthropometry; Risk factor; Young adult; Oncology","retraction":null,"screen_n_in":null,"score":{"opus":0.02850386105794462,"gpt":0.3368796144805547,"spread":0.3083757534226101,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002191805,0.0003611355,0.00093033,0.0003962979,0.0004491454,0.00006630878,0.0004081186,0.0003641637,0.0001500786],"category_scores_gemma":[0.003882159,0.000286826,0.0003179037,0.000200244,0.0007013623,0.0003705667,0.0001564597,0.0004989669,0.000004327958],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002596901,"about_ca_system_score_gemma":0.0001692451,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.007385085,"about_ca_topic_score_gemma":0.01842646,"domain_scores_codex":[0.9965856,0.0007990829,0.0009439671,0.0008994467,0.0002434697,0.000528409],"domain_scores_gemma":[0.996832,0.001043443,0.0009595532,0.0007435306,0.0002290819,0.0001923599],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001955056,0.00007200523,0.9680583,0.00005884966,0.002925253,0.00003013072,0.0002891833,0.00002692019,0.001687234,0.00007920073,0.001036691,0.0237812],"study_design_scores_gemma":[0.006212058,0.00014145,0.9318989,0.0001370222,0.001362444,0.00003653673,0.0005814178,0.05818908,0.0001497971,0.000511086,0.0005098972,0.0002703444],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9874064,0.00220508,0.001584165,0.006525691,0.0006523454,0.0008904979,0.000145816,0.00003964066,0.000550392],"genre_scores_gemma":[0.9926705,0.003508875,0.001116309,0.001618147,0.0002532027,0.0002172361,0.000308737,0.0000250181,0.0002820237],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05816216,"threshold_uncertainty_score":0.9999584,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2778648146","doi":"10.1186/s12885-017-3902-4","title":"Risk of second primary cancers in cancer patients treated with cisplatin: a systematic review and meta-analysis of randomized studies","year":2017,"lang":"en","type":"review","venue":"BMC Cancer","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"University of Toronto","keywords":"Medicine; Meta-analysis; Surgical oncology; Randomized controlled trial; Oncology; Internal medicine; Cisplatin; Cancer; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.1528070839574646,"gpt":0.4070250836227838,"spread":0.2542179996653192,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001473673,0.0007926428,0.03736544,0.0007515701,0.00005897023,0.0000124529,0.0002619315,0.0002089323,0.0009671194],"category_scores_gemma":[0.0005646121,0.0004267138,0.00346658,0.0008391834,0.0004603849,0.0001192645,0.00008487684,0.0003753222,6.105129e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001118798,"about_ca_system_score_gemma":0.002084885,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004434385,"about_ca_topic_score_gemma":0.01533496,"domain_scores_codex":[0.9944362,0.001024822,0.002926192,0.0007338589,0.0005702237,0.0003086936],"domain_scores_gemma":[0.9910359,0.001162663,0.00603363,0.001059817,0.0005808084,0.0001271989],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.001389831,0.00003608772,0.0008093769,0.6584957,0.336275,0.000003259204,0.0001410067,0.000006295068,3.250712e-8,5.518383e-7,0.0001270619,0.002715835],"study_design_scores_gemma":[0.01797452,0.00008726097,0.0002371087,0.1413627,0.8368977,0.000002001212,0.00001536585,0.00000863166,6.734912e-7,4.373086e-7,0.003088767,0.0003247651],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003541189,0.9867215,9.605292e-7,0.00001230184,0.0000504722,0.009641621,0.002836627,0.00001010666,0.0003723432],"genre_scores_gemma":[0.0001211626,0.990427,0.00007740226,0.0002085443,0.00001864069,0.006950328,0.0002114912,0.00006227213,0.001923194],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5171329,"threshold_uncertainty_score":0.9999461,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2084846190","doi":"10.1016/j.ejca.2005.01.003","title":"Active and passive smoking and risk of renal cell carcinoma in Canada","year":2005,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Health Canada","funders":"","keywords":"Renal cell carcinoma; Passive smoking; Medicine; Oncology; Carcinoma; Internal medicine; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.008782710567018053,"gpt":0.2220208348684511,"spread":0.213238124301433,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001442056,0.00007730842,0.0002281479,0.00007357691,0.00002000303,0.000004143526,0.00004283535,0.000009555871,0.0001176412],"category_scores_gemma":[0.00002396887,0.00006203284,0.00002795783,0.00005114923,0.00003829775,0.00008651079,0.0000197651,0.0002829514,1.170016e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003329048,"about_ca_system_score_gemma":0.0008908978,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.08045265,"about_ca_topic_score_gemma":0.1954779,"domain_scores_codex":[0.9992369,0.0001016189,0.0002951032,0.00008442707,0.0001721946,0.0001097139],"domain_scores_gemma":[0.9993654,0.000043452,0.0003231345,0.00005991806,0.00008848812,0.0001195491],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0007542452,0.0000166242,0.4715234,0.0000559836,0.0001110183,0.0004729114,0.001695013,0.0003944499,0.003755771,9.090602e-7,0.00190317,0.5193165],"study_design_scores_gemma":[0.003572296,0.0002172899,0.9549172,0.0001357099,0.0001272318,0.00007562607,0.0005593844,0.0001185589,0.01908383,0.000001151948,0.02111639,0.00007531181],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900249,0.004840231,0.000007450881,0.0004301979,0.00008179545,0.00004836944,0.00002024728,7.254675e-7,0.004546107],"genre_scores_gemma":[0.9969379,0.002277771,0.0001359422,0.0003301251,0.000216576,2.911053e-7,4.525634e-7,0.00001180719,0.00008910467],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5192412,"threshold_uncertainty_score":0.9256707,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2129571555","doi":"10.3748/wjg.v19.i44.8078","title":"Clinical characteristics and prognosis of young patients with colorectal cancer in Eastern China","year":2013,"lang":"en","type":"article","venue":"World Journal of Gastroenterology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"CAE (Canada)","funders":"","keywords":"Medicine; Internal medicine; Colorectal cancer; Multivariate analysis; Univariate analysis; Subgroup analysis; Proportional hazards model; Gastroenterology; Survival analysis; Stage (stratigraphy); Cancer; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.01042249687027805,"gpt":0.2691374608692679,"spread":0.2587149639989898,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001704361,0.0001033326,0.0005735363,0.000193117,0.00001137254,0.000005881275,0.00006673002,0.00003749482,0.0002420669],"category_scores_gemma":[0.00002372663,0.0000732294,0.00006289465,0.00006490933,0.000161413,0.0001087257,0.00002928628,0.0003289185,7.109778e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004665741,"about_ca_system_score_gemma":0.00006721656,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006004553,"about_ca_topic_score_gemma":0.000497202,"domain_scores_codex":[0.9987898,0.00008486015,0.0006767649,0.000113272,0.0001412142,0.0001941048],"domain_scores_gemma":[0.9991066,0.00003017581,0.0005008696,0.00006138634,0.0001700006,0.0001310077],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00443535,0.0002761976,0.9824859,0.00004160398,0.0001294274,0.00002287894,0.0001369748,0.000001406794,0.0001172613,6.410585e-7,0.0001383854,0.01221399],"study_design_scores_gemma":[0.0058138,0.004395563,0.9892356,0.0001739345,0.00007268904,0.00006674953,0.00001993716,0.0000933957,0.0000152771,0.000002290852,0.0000782787,0.00003251959],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986848,0.0000612458,0.00001904537,0.0006676912,0.0002509245,0.0002280629,0.00001145304,0.000001986875,0.00007478235],"genre_scores_gemma":[0.9989066,0.0001316924,0.0004060158,0.0003886281,0.0001056875,0.000007823322,0.000004045748,0.00001070734,0.00003879772],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01218147,"threshold_uncertainty_score":0.2986208,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W749808638","doi":"10.1016/j.clcc.2015.05.008","title":"Surgical Resection of Primary Tumor in Asymptomatic or Minimally Symptomatic Patients With Stage IV Colorectal Cancer: A Canadian Province Experience","year":2015,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Alberta; University of Saskatchewan; Saskatchewan Cancer Agency","funders":"Saskatchewan Cancer Agency","keywords":"Medicine; Hazard ratio; Asymptomatic; Primary tumor; Colorectal cancer; Surgery; Proportional hazards model; Stage (stratigraphy); Confidence interval; Chemotherapy; Cancer; Multivariate analysis; Internal medicine; Metastasis","retraction":null,"screen_n_in":null,"score":{"opus":0.04383241966405802,"gpt":0.3403864873302258,"spread":0.2965540676661678,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006736401,0.0003717267,0.00122108,0.0002733926,0.00007829138,0.00002781127,0.0002931999,0.0002439137,0.0006737633],"category_scores_gemma":[0.0006051469,0.0002752876,0.0001561361,0.0007185875,0.0005949424,0.0003219838,0.00008733088,0.000604645,0.00001279696],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002754199,"about_ca_system_score_gemma":0.01298475,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.03632608,"about_ca_topic_score_gemma":0.3477349,"domain_scores_codex":[0.9961426,0.0002697579,0.001338292,0.000737984,0.0008007704,0.0007106217],"domain_scores_gemma":[0.9972258,0.0005107543,0.0004674221,0.0003143538,0.0004650689,0.001016628],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02467661,0.0005177032,0.9656107,0.0004922756,0.0001192139,0.0003693999,0.0008592308,0.000065494,0.0001055068,0.000004758486,0.0006964839,0.00648259],"study_design_scores_gemma":[0.01449174,0.008460443,0.9698355,0.000849418,0.000107359,0.0000334436,0.0003926187,0.001636737,0.0007034268,0.000003767913,0.003037447,0.0004481587],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933708,0.000404515,0.000001128915,0.0002611253,0.0006150342,0.002021568,0.0002037803,0.00005982409,0.003062256],"genre_scores_gemma":[0.9973848,0.000123818,0.0002874723,0.0007237819,0.0001989007,0.0006621996,0.00006110421,0.00005685563,0.0005010794],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3114088,"threshold_uncertainty_score":0.99997,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1998087959","doi":"10.1038/sj.bjc.6605616","title":"Risks of second primary cancer among patients with major histological types of lung cancers in both men and women","year":2010,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"BC Cancer Agency; University of Manitoba; Manitoba Health; University of British Columbia; Saskatchewan Cancer Agency; CancerCare Manitoba","funders":"National Cancer Institute; National Institutes of Health; European Commission; Centre International de Recherche sur le Cancer","keywords":"Medicine; Lung cancer; Internal medicine; Oncology; Adenocarcinoma; Cancer; Incidence (geometry); Lung; Carcinoma; Etiology; Gynecology","retraction":null,"screen_n_in":null,"score":{"opus":0.01013186734253095,"gpt":0.2672691298764386,"spread":0.2571372625339076,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002420303,0.0001320481,0.000686103,0.0001342053,0.00002851049,0.00001026169,0.0001126753,0.0001116024,0.002147327],"category_scores_gemma":[0.00003511718,0.0001160221,0.00006266348,0.0001363988,0.0003125421,0.0002143772,0.00002796588,0.0005383858,7.187428e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005731551,"about_ca_system_score_gemma":0.0009986466,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005635158,"about_ca_topic_score_gemma":0.01321782,"domain_scores_codex":[0.9986349,0.0000353391,0.0005637715,0.0001705871,0.000349543,0.0002459073],"domain_scores_gemma":[0.9988117,0.00004715983,0.0005863173,0.0001019004,0.0002711922,0.0001817206],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001505148,0.00009306884,0.9215133,0.0003699842,0.0002932671,0.00008862743,0.0006831239,0.00003225054,0.002213048,0.000001336615,0.001233259,0.07197364],"study_design_scores_gemma":[0.006099346,0.0003652219,0.9892181,0.0006275612,0.0001288184,0.00006781936,0.00009764346,0.00002303474,0.0005907702,0.00000908774,0.00264646,0.0001260992],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9865615,0.01028026,0.000002147174,0.00005167199,0.0002313953,0.0002393112,0.0001331432,0.000003358196,0.002497255],"genre_scores_gemma":[0.9966382,0.002438052,0.0002478137,0.0002480051,0.0001079741,0.0000238333,0.000004680748,0.00001992028,0.0002714801],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07184754,"threshold_uncertainty_score":0.9987649,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1968486363","doi":"10.1016/j.canep.2010.06.015","title":"Measuring the effect of including multiple cancers in survival analyses using data from the Canadian Cancer Registry","year":2010,"lang":"en","type":"article","venue":"Cancer Epidemiology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Statistics Canada","funders":"","keywords":"Medicine; Cancer registry; Relative survival; Cancer; Internal medicine; Population; Bladder cancer; Oncology; Pancreatic cancer; Lung cancer; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.4495041018642483,"gpt":0.4763173160602888,"spread":0.02681321419604055,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003208753,0.0002756884,0.001030565,0.0001146811,0.0003063803,0.00001037185,0.0009351504,0.0002607254,0.000463008],"category_scores_gemma":[0.004414341,0.0001603239,0.000132862,0.0003298952,0.0005992071,0.0001221327,0.0002310108,0.001183544,0.000002539211],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00123055,"about_ca_system_score_gemma":0.003248686,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9636856,"about_ca_topic_score_gemma":0.9864707,"domain_scores_codex":[0.9969897,0.0008474407,0.0006835405,0.0006311061,0.0001906698,0.0006574907],"domain_scores_gemma":[0.9925447,0.005154039,0.0004140495,0.00157022,0.00008404916,0.0002329031],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002776388,0.000003426626,0.9717852,0.0000640318,0.000284146,0.00001167866,0.0002191839,0.005819155,0.01355005,0.000009922669,0.002452093,0.005523464],"study_design_scores_gemma":[0.002987331,0.00007927009,0.8721923,0.0004356252,0.0005850774,0.00001332917,0.0002748741,0.08652891,0.004042282,0.00006682405,0.03242937,0.0003647813],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9791458,0.01078858,0.00004921666,0.006027721,0.002377645,0.000543655,0.0007209437,0.00001664358,0.0003298564],"genre_scores_gemma":[0.995363,0.0006293391,0.0002555536,0.002368673,0.001067218,0.00008861584,0.0001623601,0.00003292444,0.00003232925],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09959289,"threshold_uncertainty_score":0.653782,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2970643758","doi":"10.1186/s12885-019-6074-6","title":"Impact of prior malignancies on outcome of colorectal cancer; revisiting clinical trial eligibility criteria","year":2019,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Malignancy; Internal medicine; Colorectal cancer; Oncology; Cancer; Surgical oncology; Stage (stratigraphy); Clinical trial","retraction":null,"screen_n_in":null,"score":{"opus":0.1204069132200527,"gpt":0.4945583027634433,"spread":0.3741513895433906,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007953048,0.0002040377,0.001145093,0.00008050557,0.00002546659,0.000007795306,0.0001367753,0.0001497285,0.003867502],"category_scores_gemma":[0.0004757004,0.0001553216,0.0006641109,0.000161625,0.0001336543,0.00008320921,0.00004987719,0.0002407485,0.00001004086],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004440499,"about_ca_system_score_gemma":0.001615636,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001369907,"about_ca_topic_score_gemma":0.0001350112,"domain_scores_codex":[0.9976054,0.0001282861,0.001172147,0.0004182495,0.0003937346,0.0002821935],"domain_scores_gemma":[0.9982741,0.0003888368,0.0005465531,0.000438489,0.0002182534,0.0001337297],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0640971,0.0001430485,0.9055593,0.0006431095,0.000152267,0.000001944393,0.0001251311,0.0000432145,0.01580214,0.00001194072,0.0006256599,0.01279514],"study_design_scores_gemma":[0.0326266,0.002687426,0.9571487,0.0004894721,0.0001359961,0.0000021939,0.00004555482,0.00027772,0.005792167,0.000005970728,0.0006169564,0.0001712041],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946414,0.0006864389,0.000005393586,0.00008322818,0.001198099,0.001243379,0.0002641615,0.00002367986,0.00185424],"genre_scores_gemma":[0.9980438,0.0002710593,0.0003252555,0.0002331642,0.0006249259,0.00005688556,0.00001302952,0.00002467678,0.0004071887],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05158944,"threshold_uncertainty_score":0.9970431,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1975696113","doi":"10.1023/a:1023926401227","title":"Risk Factors for Colorectal Cancer Following Breast Cancer","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Cancer Foundation; University of Calgary","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Colorectal cancer; Family history; Cancer; Oncology; Internal medicine; Odds ratio; Gynecology; Cancer registry; Population; Epidemiology; Epidemiology of cancer; Body mass index","retraction":null,"screen_n_in":null,"score":{"opus":0.05558737688816778,"gpt":0.3786550019926228,"spread":0.323067625104455,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002823347,0.0003560627,0.0005597939,0.0002042567,0.0005785689,0.00007249045,0.00009025518,0.0001290832,0.001549202],"category_scores_gemma":[0.00002975937,0.0002552241,0.0002599329,0.0003244755,0.0001900538,0.0001663872,0.00003218864,0.0002770053,0.000006154914],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002204754,"about_ca_system_score_gemma":0.001798571,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03342097,"about_ca_topic_score_gemma":0.005762062,"domain_scores_codex":[0.9974024,0.0001226161,0.0002687063,0.0007007252,0.0005232388,0.0009823492],"domain_scores_gemma":[0.9985092,0.0002514739,0.00007701486,0.0002602469,0.0002719429,0.0006300943],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003522955,0.0005267664,0.848047,0.0001182236,0.001851791,0.00006047818,0.0008271484,0.00003112224,0.002292799,0.0001140528,0.001948321,0.1406594],"study_design_scores_gemma":[0.01545111,0.001516728,0.9358333,0.0003027775,0.0006095571,0.0001556315,0.001032382,0.0001953974,0.01089005,0.0001334023,0.03335186,0.0005278134],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9840408,0.006598941,0.00001109419,0.001725322,0.0003932308,0.001751374,0.004584947,0.00005118204,0.000843134],"genre_scores_gemma":[0.9839949,0.01041294,0.00009229059,0.0001101177,0.0003492502,0.002839862,0.00007439788,0.00006423074,0.00206199],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1401316,"threshold_uncertainty_score":0.99999,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2946842905","doi":"10.1111/bju.14841","title":"Long‐term incidence of secondary bladder and rectal cancer in patients treated with brachytherapy for localized prostate cancer: a large‐scale population‐based analysis","year":2019,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Brachytherapy; Prostate cancer; Prostatectomy; Incidence (geometry); Hazard ratio; Bladder cancer; Propensity score matching; Confounding; Cumulative incidence; Urology; Internal medicine; Proportional hazards model; Population; Epidemiology; Surgery; Cancer; Confidence interval; Radiation therapy; Cohort","retraction":null,"screen_n_in":null,"score":{"opus":0.005614532374422019,"gpt":0.2583114780045528,"spread":0.2526969456301308,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002069618,0.0001208354,0.0007155385,0.0003051799,0.00003020944,0.00001163909,0.00006572553,0.00009637308,0.0006032236],"category_scores_gemma":[0.00002006672,0.0001134787,0.0001216286,0.0003265276,0.00006007075,0.0001652297,0.00001086484,0.0002336846,1.56622e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000108928,"about_ca_system_score_gemma":0.0003588111,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001236218,"about_ca_topic_score_gemma":0.00784209,"domain_scores_codex":[0.9987592,0.00008572215,0.0005289015,0.0002119645,0.000184928,0.0002293589],"domain_scores_gemma":[0.9989476,0.0000707547,0.0004624386,0.0001008722,0.0003204914,0.00009779773],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007592756,0.0001587213,0.9553109,0.0001046448,0.0005993645,0.00006773663,0.000191801,0.001043055,0.0001670607,2.21542e-7,0.00004592252,0.03471786],"study_design_scores_gemma":[0.01851834,0.001993427,0.9767641,0.0001430176,0.0005317013,0.0001141013,0.00001766533,0.001544642,0.0001454634,0.000005058434,0.0001134044,0.0001090872],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954653,0.003308156,0.0001262488,0.000211925,0.00006969103,0.0005255774,0.0002712327,0.000004566046,0.00001726953],"genre_scores_gemma":[0.9978685,0.0008407184,0.0002433486,0.0008079772,0.00003291333,0.00002372863,0.00009426763,0.00001904589,0.00006947381],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03460877,"threshold_uncertainty_score":0.6604875,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2210721194","doi":"10.1200/jco.2006.24.18_suppl.7009","title":"Adjuvant chemotherapy in elderly patients: An analysis of National Cancer Institute of Canada Clinical Trials Group and Intergroup BR.10","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Vinorelbine; Chemotherapy; Internal medicine; Toxicity; Cisplatin; Adjuvant; Young adult; Univariate analysis; Cancer; Gastroenterology; Multivariate analysis; Oncology; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.1391649794315419,"gpt":0.49661206891576,"spread":0.3574470894842181,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008688191,0.0001280646,0.00326796,0.0003253063,0.00001529178,0.000003417957,0.0001460128,0.0003026231,0.0005750047],"category_scores_gemma":[0.003712942,0.00009389692,0.0005765993,0.0003042271,0.000287661,0.0001802425,0.00002276356,0.00056839,1.14308e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003764221,"about_ca_system_score_gemma":0.0056208,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.04484975,"about_ca_topic_score_gemma":0.4433409,"domain_scores_codex":[0.9922218,0.0008632618,0.006020774,0.000212425,0.0005201475,0.0001615302],"domain_scores_gemma":[0.9925826,0.00272297,0.003636967,0.0001332922,0.0006886104,0.0002355588],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009154133,0.002119945,0.777764,0.00003257412,0.001631985,0.00003899727,0.00005018042,0.000250722,0.0001022059,0.00007025416,0.005724465,0.2030605],"study_design_scores_gemma":[0.01712897,0.006748569,0.9334503,0.00006760287,0.0007292686,0.000004954416,0.00004704808,0.0008797402,0.0000204039,0.00008576601,0.04075793,0.00007941773],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957489,0.0004430629,0.00006601764,0.001550085,0.001145504,0.0001706759,0.00005656945,0.000001594774,0.0008175492],"genre_scores_gemma":[0.9950817,0.0008812086,0.0008393055,0.002359084,0.0006895638,0.000002845743,0.00003625509,0.000008607239,0.0001014569],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3984911,"threshold_uncertainty_score":0.9971057,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4319968648","doi":"10.1186/s13058-023-01610-x","title":"Risks of second non-breast primaries following breast cancer in women: a systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"Breast Cancer Research","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"NIHR Cambridge Biomedical Research Centre; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Breast cancer; Meta-analysis; Incidence (geometry); Internal medicine; Surgical oncology; Oncology; Demography; Gynecology; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.2595119031484425,"gpt":0.4922958054506487,"spread":0.2327839023022061,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005654929,0.0009778906,0.01706553,0.002454662,0.0001825126,0.0001152512,0.0007599944,0.0004596594,0.008587865],"category_scores_gemma":[0.000135249,0.0006803153,0.003378749,0.006371147,0.0003911935,0.0002699266,0.0005326272,0.001871345,0.00004562468],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002694562,"about_ca_system_score_gemma":0.005132614,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007879471,"about_ca_topic_score_gemma":0.003183116,"domain_scores_codex":[0.9910564,0.001420908,0.002658295,0.001488616,0.00192866,0.001447104],"domain_scores_gemma":[0.9952716,0.0008912252,0.0009194208,0.001617091,0.0006815331,0.0006191172],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.000113233,0.00008009325,0.0001001818,0.8199891,0.1531952,0.0001387517,0.0002477869,0.000001976762,0.000001103175,0.000003751523,0.0006147861,0.02551407],"study_design_scores_gemma":[0.001241543,0.00007380017,0.002310761,0.2592842,0.7223554,0.000744951,0.0003190775,0.0000200251,4.957477e-7,0.000008890646,0.01271926,0.0009216013],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008258277,0.9800461,0.000001099027,0.001179795,0.00008700159,0.006803199,0.01149148,0.00004377822,0.0002649981],"genre_scores_gemma":[0.0004999174,0.9824381,0.00001351093,0.0004167015,0.0001340222,0.01228528,0.0001534793,0.0001897919,0.003869206],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5691603,"threshold_uncertainty_score":0.9995648,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3204126457","doi":"10.3390/curroncol28050330","title":"The Challenge of Return to Work after Breast Cancer: The Role of Family Situation, CANTO Cohort","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false},"ca_institutions":"","funders":"Agence Nationale de la Recherche","keywords":"Medicine; Canto; Breast cancer; Cohort; Cancer; Work (physics); Internal medicine; Linguistics","retraction":null,"screen_n_in":null,"score":{"opus":0.0416991644271028,"gpt":0.3525309745874912,"spread":0.3108318101603884,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000262048,0.0000996548,0.0003195108,0.00003019001,0.00005973937,0.00000392232,0.0001336228,0.00006623024,0.0003841513],"category_scores_gemma":[0.00005496331,0.00005936603,0.00009022339,0.000214574,0.0001512843,0.00002337934,0.00007866179,0.0002107906,0.000006070014],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002327517,"about_ca_system_score_gemma":0.0009863294,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001458794,"about_ca_topic_score_gemma":0.001108081,"domain_scores_codex":[0.9989558,0.000111621,0.0003313296,0.0001989852,0.0002071228,0.0001951013],"domain_scores_gemma":[0.998866,0.0001731062,0.0001260508,0.0003854684,0.0003647418,0.00008463742],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001049175,0.0002865797,0.2694238,0.0001052575,0.0001893084,0.00001148579,0.003947652,0.00001128896,0.00188657,0.0002143923,0.007200017,0.7156745],"study_design_scores_gemma":[0.0007117738,0.0001576413,0.5239118,0.0001075761,0.0001439869,0.00001338313,0.001189993,0.00004820565,0.0007354238,0.0001256671,0.472781,0.00007361108],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9165432,0.05303025,0.00002345141,0.02099833,0.001502402,0.0006078042,0.0001069173,0.00001208541,0.007175507],"genre_scores_gemma":[0.9936898,0.005006828,0.00002659629,0.0005915469,0.0002992311,0.0001668302,0.00001964824,0.00001040509,0.0001891307],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7156008,"threshold_uncertainty_score":0.4206188,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4214884454","doi":"10.1200/po.21.00286","title":"Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC Study","year":2022,"lang":"en","type":"article","venue":"JCO Precision Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"St. Baldrick's Foundation; Hospital for Sick Children; Bristol-Myers Squibb","keywords":"Somatic hypermutation; Immune checkpoint; Immune system; Medicine; Oncology; Immunology; Immunotherapy; Antibody; B cell","retraction":null,"screen_n_in":null,"score":{"opus":0.04808232243282154,"gpt":0.3559539374760146,"spread":0.307871615043193,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001001428,0.0002046284,0.0005356231,0.0002055782,0.0005249488,0.00002454812,0.0001312044,0.0001032613,0.00279135],"category_scores_gemma":[0.0001417389,0.0001992905,0.0001645168,0.0002292141,0.00006217232,0.0001954785,0.0001093617,0.0003589166,0.00001678271],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002880329,"about_ca_system_score_gemma":0.001256378,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003902602,"about_ca_topic_score_gemma":0.0001192713,"domain_scores_codex":[0.9977201,0.0003222155,0.0006564577,0.0005712612,0.000385809,0.0003441091],"domain_scores_gemma":[0.9986372,0.0003621049,0.0002929512,0.0003887916,0.0001713227,0.0001476429],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.008494086,0.002996937,0.0007527857,0.00003316373,0.0001467572,0.0002117997,0.00855598,0.001330487,0.2702861,0.00004362719,0.001251997,0.7058963],"study_design_scores_gemma":[0.07830066,0.2003094,0.03257021,0.0001182913,0.0003981896,0.001775985,0.06999581,0.009634104,0.08564609,0.001720945,0.5180873,0.001443024],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886605,0.000643334,0.0003915235,0.001133012,0.0009038496,0.002801484,0.00003508466,0.0001097063,0.005321475],"genre_scores_gemma":[0.9937724,0.00006127782,0.001468478,0.002121547,0.0003836579,0.001236815,0.0003113112,0.00005092027,0.000593525],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7044533,"threshold_uncertainty_score":0.9981202,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3193781013","doi":"10.3390/curroncol28010035","title":"The Impact of Radiotherapy on the Incidence of Secondary Malignancies: A Pan-Cancer Study in the US SEER Cancer Registries","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false},"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Oncology; Internal medicine; Surveillance, Epidemiology, and End Results; Epidemiology; Cancer; Population; Adenocarcinoma; Incidence (geometry); Breast cancer; Cancer registry","retraction":null,"screen_n_in":null,"score":{"opus":0.1020933159099037,"gpt":0.4433463188099095,"spread":0.3412530029000058,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008287599,0.0001791005,0.0005203148,0.00005323792,0.0001108697,0.00001312142,0.0003554831,0.00007264873,0.0008495492],"category_scores_gemma":[0.0002169959,0.00007980981,0.0001926244,0.0003985677,0.0004320532,0.00005082551,0.00005425402,0.0005389372,0.000001395762],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005941523,"about_ca_system_score_gemma":0.003327736,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001175405,"about_ca_topic_score_gemma":0.0027281,"domain_scores_codex":[0.9981007,0.0005554562,0.0004856033,0.0002593582,0.000318246,0.0002806673],"domain_scores_gemma":[0.9976236,0.001186221,0.0003080365,0.0006267434,0.0002157883,0.00003965239],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002226996,0.001710598,0.7133137,0.0001797924,0.0006520841,0.00009135641,0.02269659,0.0002238725,0.004883901,0.0002781523,0.03751075,0.2162322],"study_design_scores_gemma":[0.003704808,0.002473386,0.8703144,0.000267804,0.0001129474,0.0000361111,0.007686411,0.0001721865,0.001489772,0.00007815819,0.1135249,0.0001391453],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.961735,0.03152048,0.00000517879,0.004175661,0.0006290095,0.000875206,0.00007554945,0.000006160066,0.0009777723],"genre_scores_gemma":[0.9859715,0.01241764,0.000006714909,0.0008838496,0.0001905514,0.0003143178,0.000007169347,0.00001335225,0.0001949071],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2160931,"threshold_uncertainty_score":0.9301968,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3116667756","doi":"10.3747/co.27.5951","title":"The Cost of Failed First-Line Cancer Treatment Related to Continued Smoking in Canada","year":2020,"lang":"en","type":"article","venue":"Current Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true},"ca_institutions":"Canada Research Chairs; Canadian Partnership Against Cancer","funders":"","keywords":"Medicine; Lung cancer; Cancer; Breast cancer; Prostate cancer; Colorectal cancer; Disease; Smoking cessation; Cancer treatment; Environmental health; Internal medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.1070228115516471,"gpt":0.3858826717102338,"spread":0.2788598601585867,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007525433,0.0001137873,0.0004125631,0.00003055025,0.00004393055,0.000002643092,0.00008946223,0.00004490564,0.0003237955],"category_scores_gemma":[0.0001070586,0.00007825314,0.00004752599,0.0001989223,0.00003806897,0.00001626679,0.00003168636,0.00018104,0.000003253861],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002745084,"about_ca_system_score_gemma":0.002935725,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.2544331,"about_ca_topic_score_gemma":0.8961657,"domain_scores_codex":[0.9990077,0.00005429929,0.0003805032,0.0001997096,0.0001207172,0.0002370633],"domain_scores_gemma":[0.9993059,0.0002108842,0.0001083459,0.0001386229,0.0000622228,0.0001739963],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001197674,0.000122779,0.4004971,0.00007827006,0.0001438091,0.00007284949,0.002298026,0.0007401882,0.000323908,0.00004480699,0.01106454,0.583416],"study_design_scores_gemma":[0.005906168,0.0007203864,0.0965166,0.00008043203,0.00007027764,0.000002583477,0.0004173558,0.002044875,0.0007117405,0.000005079981,0.8934305,0.00009399485],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9689528,0.003725594,0.0000147083,0.02409081,0.001110089,0.0009183419,0.00006115325,0.00001190478,0.001114548],"genre_scores_gemma":[0.9969799,0.001564938,0.00001106009,0.00108193,0.00008247761,0.0001465227,0.00003362585,0.00001030337,0.00008922799],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8823659,"threshold_uncertainty_score":0.7505317,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2407608804","doi":"10.7150/jca.14717","title":"Surgical Management of the Primary Tumor in Stage IV Colorectal Cancer: A Confirmatory Retrospective Cohort Study","year":2016,"lang":"en","type":"article","venue":"Journal of Cancer","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Alberta; Saskatchewan Health; Saskatchewan Cancer Agency; University of Saskatchewan","funders":"Saskatchewan Cancer Agency","keywords":"Medicine; Hazard ratio; Internal medicine; Colorectal cancer; FOLFOX; Proportional hazards model; FOLFIRI; Retrospective cohort study; Stage (stratigraphy); Chemotherapy; Surgery; Cancer; Oncology; Irinotecan; Confidence interval; Oxaliplatin","retraction":null,"screen_n_in":null,"score":{"opus":0.01078271806124357,"gpt":0.2918928437994907,"spread":0.2811101257382471,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005750021,0.000142207,0.0006428983,0.0001098255,0.000032527,0.000005773616,0.0001930409,0.00003960617,0.001243718],"category_scores_gemma":[0.00001367337,0.00007453144,0.0002179081,0.0002067924,0.0001374509,0.0001261391,0.00006660078,0.0002888811,0.000001130674],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001724752,"about_ca_system_score_gemma":0.0007604206,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002335288,"about_ca_topic_score_gemma":0.0003097731,"domain_scores_codex":[0.9981509,0.0001001496,0.0006528095,0.0001735511,0.0007132728,0.0002093282],"domain_scores_gemma":[0.998879,0.00005728737,0.0005510245,0.0001934047,0.0002189277,0.0001003414],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002314759,0.0002626213,0.9882488,0.0001161585,0.0007031786,0.0005628075,0.0002930054,0.00001156269,0.001639093,0.00002712959,0.001215103,0.004605845],"study_design_scores_gemma":[0.008334709,0.0004232799,0.9802163,0.0005983204,0.0002309235,0.00004540991,0.0003527661,0.000004339654,0.001966989,0.000007868024,0.00772611,0.00009303712],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913925,0.001931548,0.000002376285,0.0007155209,0.0006527315,0.0008081912,0.00004522303,0.000005061333,0.004446825],"genre_scores_gemma":[0.9963792,0.001740726,0.00002239165,0.0002810776,0.0002162587,0.00005524137,2.980468e-7,0.00001679105,0.001288039],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008032489,"threshold_uncertainty_score":0.9996693,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2145046237","doi":"","title":"Radiation-induced second malignancies.","year":2015,"lang":"en","type":"article","venue":"PubMed","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"London Health Sciences Centre; Western University; Manitoba Beekeepers' Association; Saskatchewan Health","funders":"","keywords":"Medicine; Radiation therapy; Cancer; Thyroid cancer; Sarcoma; Etiology; Oncology; Internal medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.06257628559922351,"gpt":0.2542505515920383,"spread":0.1916742659928148,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002441984,0.00009005891,0.0001775367,0.00007156,0.00002602609,0.00001539835,0.00006106439,0.00006146794,0.0003776209],"category_scores_gemma":[0.0001326576,0.00008089413,0.00005478123,0.0001241306,0.00002147382,0.0001270246,0.00001824935,0.0001042491,0.00008063519],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002174867,"about_ca_system_score_gemma":0.00022141,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002966838,"about_ca_topic_score_gemma":0.00001493502,"domain_scores_codex":[0.9991699,0.0000183839,0.0001610286,0.0001754859,0.0001956767,0.0002794574],"domain_scores_gemma":[0.9992576,0.00002157852,0.00004505318,0.0002252959,0.00006987909,0.0003806106],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0003023385,0.00008743077,0.03526912,0.00007205539,0.0001259856,0.00008277151,0.0006869347,0.000003847098,0.001019112,0.0002550906,0.1496121,0.8124832],"study_design_scores_gemma":[0.002984432,0.00004955278,0.5876026,0.000003379574,0.00003066572,0.00004024563,0.00009954686,0.00003907607,0.007012828,0.00007557159,0.401931,0.0001310653],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8700261,0.0005618533,0.00001498326,0.001263635,0.0006363622,0.0006665455,0.00001018591,0.00008106069,0.1267394],"genre_scores_gemma":[0.985013,0.00001195498,0.00009026616,0.003668669,0.0003421103,0.0004777272,0.000032736,0.0000157106,0.01034783],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8123521,"threshold_uncertainty_score":0.4134684,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2177715379","doi":"10.1111/bju.13351","title":"Trends in the risk of second primary cancer among bladder cancer survivors: a population‐based cohort of 10 047 patients","year":2015,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Institute of Cancer Research; Institut de Veille Sanitaire; Institut National Du Cancer","keywords":"Medicine; Bladder cancer; Poisson regression; Confidence interval; Lung cancer; Incidence (geometry); Population; Cohort; Internal medicine; Cancer; Prostate cancer; Cancer registry; Relative risk; Multivariate analysis; Oncology","retraction":null,"screen_n_in":null,"score":{"opus":0.01660676445640518,"gpt":0.2698471438441277,"spread":0.2532403793877225,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008014827,0.0001167662,0.0006127023,0.0002897515,0.00002515496,0.000007129976,0.0001817643,0.0001295361,0.002183996],"category_scores_gemma":[0.0001475452,0.0001003377,0.0001692513,0.0002820995,0.000141783,0.0001457876,0.00002102669,0.0004232474,4.412707e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001574415,"about_ca_system_score_gemma":0.0004641687,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01795384,"about_ca_topic_score_gemma":0.02988594,"domain_scores_codex":[0.9980852,0.0003306663,0.000806472,0.0001474289,0.0004247128,0.0002055152],"domain_scores_gemma":[0.9982936,0.0001325444,0.0008393837,0.0001611708,0.0004598817,0.0001134433],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000790444,0.0002187898,0.9564883,0.00004217829,0.0002104185,0.00007219319,0.0003323298,0.0008409398,0.00003099006,6.566641e-7,0.006475222,0.0344976],"study_design_scores_gemma":[0.005045618,0.0006411368,0.9904154,0.00007428786,0.0002660823,0.00009407948,0.00004935548,0.0001675646,0.00003190237,0.0000186573,0.003114417,0.00008151228],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938055,0.003508686,0.000009129199,0.000233751,0.0003311893,0.0001681734,0.0002101129,0.000002937361,0.001730569],"genre_scores_gemma":[0.9980487,0.0004702558,0.00007382968,0.0009622587,0.0001478399,0.00001291224,0.00006948233,0.00001652884,0.0001982572],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03441609,"threshold_uncertainty_score":0.9987282,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3183089822","doi":"10.1093/jnci/djab138","title":"Development and Validation of a Risk Prediction Model for Second Primary Lung Cancer","year":2021,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; Brock University","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Brier score; Quartile; Internal medicine; Confidence interval; Receiver operating characteristic; Oncology; Lung cancer; Population; Proportional hazards model; Cohort; Statistics","retraction":null,"screen_n_in":null,"score":{"opus":0.05132450612951987,"gpt":0.3293561321618461,"spread":0.2780316260323262,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003452293,0.00008549225,0.0002222874,0.00008405135,0.000114236,0.00001121363,0.00006952289,0.00005520571,0.00007848952],"category_scores_gemma":[0.0001570904,0.00006327275,0.0001085065,0.0001202894,0.00005066334,0.0002966147,0.00002917933,0.0001788096,6.890044e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00078661,"about_ca_system_score_gemma":0.004589887,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001088591,"about_ca_topic_score_gemma":0.0001288999,"domain_scores_codex":[0.9988046,0.00001962023,0.0004749501,0.0001115788,0.0005014514,0.00008775446],"domain_scores_gemma":[0.998263,0.00005055432,0.0004859355,0.00005931082,0.001081552,0.0000596553],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.006049466,0.0006502097,0.1566097,0.004456424,0.004842435,0.00001880848,0.01303251,0.4107654,0.2092876,0.001782833,0.07528132,0.1172233],"study_design_scores_gemma":[0.01725375,0.0001384498,0.2801582,0.001826947,0.001575947,0.0003927181,0.00017123,0.1396712,0.3653114,0.001418929,0.1916296,0.0004515953],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9899575,0.002610067,0.004039673,0.0008364543,0.001238257,0.0002374301,0.0005165333,0.000004017331,0.0005600869],"genre_scores_gemma":[0.9791642,0.001152814,0.01591245,0.00164907,0.0009081851,0.0000537487,0.00005761655,0.00001590192,0.001085963],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2710943,"threshold_uncertainty_score":0.8142263,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2901559050","doi":"10.2188/jea.je20180140","title":"Premature Mortality Due to Malignancies of the Kidney and Bladder in Japan, 1980–2010","year":2018,"lang":"en","type":"article","venue":"Journal of Epidemiology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Health Services","funders":"University of Occupational and Environmental Health; Alberta Health Services","keywords":"Medicine; Population; Kidney; Internal medicine; Demography; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.05184164958637681,"gpt":0.3416288887184226,"spread":0.2897872391320458,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002052251,0.00009719599,0.0007149545,0.0001013725,0.00002665958,0.000001497538,0.0001312087,0.0001448661,0.0001846923],"category_scores_gemma":[0.005401099,0.00005496113,0.0001168611,0.0001257131,0.0002868942,0.00005823461,0.00005859302,0.0003618393,0.000002170339],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004713742,"about_ca_system_score_gemma":0.0002794194,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001206934,"about_ca_topic_score_gemma":0.0001678818,"domain_scores_codex":[0.9985079,0.0002882992,0.0007699204,0.0001274192,0.00009979639,0.0002067367],"domain_scores_gemma":[0.9985132,0.0004236427,0.0004417751,0.0002466982,0.000173431,0.0002013007],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000496621,0.00005490402,0.9115514,0.0001165105,0.0001602082,0.00002728258,0.001055028,0.00001200967,0.01651836,0.0006262033,0.06753114,0.001850335],"study_design_scores_gemma":[0.0008185923,0.0005012712,0.975031,0.0001985137,0.0000634442,0.0004883134,0.0001053602,0.00004697216,0.001391985,0.0009383475,0.02036332,0.00005290368],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9818856,0.0007512801,0.00007451489,0.01550938,0.0006622527,0.0001536422,0.00001061998,0.000002114945,0.0009505721],"genre_scores_gemma":[0.9763285,0.0001446942,0.001844194,0.02092409,0.00043523,0.00000184169,0.000001205632,0.000007484939,0.0003127735],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06347958,"threshold_uncertainty_score":0.646601,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2805506778","doi":"10.1080/10245332.2018.1466428","title":"Synchronous dual hematological malignancies: new or underreported entity?","year":2018,"lang":"en","type":"article","venue":"Hematology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Royal Victoria Regional Health Centre","funders":"","keywords":"Malignancy; Medicine; Hematological malignancy; Hematologic malignancy; Internal medicine; Retrospective cohort study; Hematological disorders; Cancer; Hematologic Neoplasms; Oncology","retraction":null,"screen_n_in":null,"score":{"opus":0.05035532375406432,"gpt":0.3212731621708292,"spread":0.2709178384167649,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001164284,0.0002182992,0.0007072446,0.0001127723,0.0001159052,0.00001451083,0.0001052923,0.000272033,0.0133358],"category_scores_gemma":[0.0002689723,0.0001602374,0.0001232927,0.0002162602,0.0004004929,0.00008825176,0.00008351316,0.0002057233,0.0008179788],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000103732,"about_ca_system_score_gemma":0.00101415,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000104424,"about_ca_topic_score_gemma":0.0002402325,"domain_scores_codex":[0.9982843,0.00004542112,0.0004969028,0.0004690776,0.0002002606,0.0005040806],"domain_scores_gemma":[0.9988467,0.0001164455,0.0001412846,0.0004757502,0.0001086754,0.000311182],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005904709,0.001364477,0.120334,0.001397312,0.001317521,0.02761305,0.002900093,0.000001911313,0.01398963,0.07030902,0.738664,0.01620428],"study_design_scores_gemma":[0.01842526,0.007031208,0.0388354,0.0005739119,0.0007724805,0.2144301,0.002027394,0.000933407,0.07030732,0.005642361,0.6392668,0.001754394],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9534923,0.0009313061,0.004832945,0.003668587,0.001158229,0.0005915499,0.000006880097,0.0003901548,0.03492802],"genre_scores_gemma":[0.9850162,0.00005704936,0.003469692,0.004373614,0.0004043163,0.00001908536,0.00003774081,0.00002811158,0.006594148],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.186817,"threshold_uncertainty_score":0.99996,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1635162237","doi":"10.1186/1742-7622-3-17","title":"Identifying related cancer types based on their incidence among people with multiple cancers","year":2006,"lang":"en","type":"article","venue":"Emerging Themes in Epidemiology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"National Cancer Institute; Michael Smith Health Research BC","keywords":"Cancer; Medicine; Medical diagnosis; Population; Incidence (geometry); Epidemiology; Demography; Cancer registry; Epidemiology of cancer; Internal medicine; Pathology; Environmental health; Breast cancer; Mathematics","retraction":null,"screen_n_in":null,"score":{"opus":0.02693601974379932,"gpt":0.3129361068558759,"spread":0.2860000871120766,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009090169,0.0003004865,0.000798923,0.0002894925,0.0001230591,0.000005682114,0.0001946864,0.0001826532,0.0005939875],"category_scores_gemma":[0.0005992553,0.0002241904,0.0001209937,0.0004630627,0.0002367267,0.0001218696,0.00003421283,0.0005549137,0.00001145075],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006559386,"about_ca_system_score_gemma":0.0003318286,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.02184249,"about_ca_topic_score_gemma":0.02132642,"domain_scores_codex":[0.9976104,0.0003259465,0.0006562085,0.0006049425,0.000155606,0.0006468871],"domain_scores_gemma":[0.9976096,0.001463869,0.0002880605,0.0004729484,0.00006283994,0.0001027402],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004575526,0.00003963862,0.8909745,0.00006806223,0.00005372333,0.00003230619,0.0004875396,0.1037511,0.0006385954,0.0001371018,0.001392488,0.001967328],"study_design_scores_gemma":[0.002482814,0.0001856438,0.8769538,0.0005610782,0.00004972311,0.00001385398,0.000259714,0.1151966,0.001064201,0.0006611216,0.00225558,0.0003158236],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9884573,0.002084516,0.0006709849,0.002498101,0.0004602231,0.0004386439,0.00001482149,0.0001307159,0.005244671],"genre_scores_gemma":[0.9950961,0.0002599678,0.001280937,0.00236173,0.000157445,0.0001559166,0.00006759237,0.00004938388,0.0005708832],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01402068,"threshold_uncertainty_score":0.9965318,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2342975205","doi":"10.1097/md.0000000000003491","title":"Multiple Primary Malignancies in Patients With Hepatocellular Carcinoma","year":2016,"lang":"en","type":"article","venue":"Medicine","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"CAE (Canada)","funders":"National Institute on Alcohol Abuse and Alcoholism; Specialized Research Fund for the Doctoral Program of Higher Education of China; National Natural Science Foundation of China","keywords":"Medicine; Hepatocellular carcinoma; Oncology; Internal medicine; Carcinoma; Primary (astronomy)","retraction":null,"screen_n_in":null,"score":{"opus":0.01216431125133615,"gpt":0.2050815804179596,"spread":0.1929172691666234,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001654506,0.0001997295,0.0004713363,0.0001969485,0.00003353396,0.000002315193,0.00009416905,0.00006921175,0.0007260552],"category_scores_gemma":[0.0001079007,0.000101131,0.00003744264,0.0002136239,0.0002236856,0.0001161102,0.00003159138,0.0001205608,0.00003480856],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002786905,"about_ca_system_score_gemma":0.0001551969,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001591742,"about_ca_topic_score_gemma":0.00002616106,"domain_scores_codex":[0.998538,0.0000309997,0.0003212076,0.0003369613,0.0004302677,0.0003425469],"domain_scores_gemma":[0.9991441,0.0001034258,0.00007554812,0.0003909378,0.0001066149,0.0001794249],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001004378,0.0001031944,0.9769167,0.00009596099,0.00002556181,0.0001116285,0.0002289576,1.853796e-7,0.00795378,0.00001432387,0.002046997,0.0114983],"study_design_scores_gemma":[0.01899017,0.001090089,0.96515,0.0004966609,0.00004765738,0.000008808554,0.0000430596,0.00002534164,0.001209827,0.00001050619,0.01277611,0.0001517784],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921553,0.0004168394,0.0001564557,0.002897565,0.0001525361,0.0005683479,0.00001284021,0.00004704319,0.003593117],"genre_scores_gemma":[0.9956317,0.00004372887,0.0002439505,0.002183014,0.0001636574,0.00003117134,0.00007753594,0.00003102486,0.001594229],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01798579,"threshold_uncertainty_score":0.7949795,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2997322954","doi":"10.1002/9780471420194.tnmm04","title":"Principles of Cancer Staging","year":2017,"lang":"en","type":"other","venue":"TNM Online","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"TNM staging system; Medicine; Cancer; Staging system; Oncology; Distant metastasis; Stage (stratigraphy); Lymph node; Cancer staging; Lymph node metastasis; Disease; Internal medicine; AJCC staging system; Metastasis; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.06139056889505708,"gpt":0.3757026594070146,"spread":0.3143120905119576,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00004339789,0.0001818672,0.0005417215,0.0001452633,0.00002181155,0.000004536589,0.0001587995,0.0001604751,0.03317283],"category_scores_gemma":[0.00004248964,0.0001522908,0.000104955,0.00002907625,0.0001011818,0.00001738062,0.00005593824,0.0002126274,0.00001834981],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007061385,"about_ca_system_score_gemma":0.0005258856,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001526686,"about_ca_topic_score_gemma":0.002109139,"domain_scores_codex":[0.9992212,0.000008821014,0.0001875763,0.0002254064,0.0001895066,0.0001674806],"domain_scores_gemma":[0.9988927,0.00001462586,0.000365141,0.0006059184,0.00003763722,0.00008396254],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009786977,0.0001240062,0.005743518,0.001374495,0.0004452229,0.00005433013,0.00007155105,0.000001992056,0.0005628483,0.00004863244,0.8913481,0.1001275],"study_design_scores_gemma":[0.0008851633,0.00004443865,0.003907853,0.001630394,0.000132818,0.000002295372,0.00001008991,0.00006065802,0.000174367,0.000001014953,0.9930136,0.0001373122],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.0009002275,0.0066348,0.0000103989,0.0003727243,0.0004192859,0.0003244542,0.006502353,0.00009725901,0.9847385],"genre_scores_gemma":[0.0002275363,0.003674475,0.001778113,0.0003851801,0.001055301,0.00001306487,0.001311175,0.0002420455,0.9913131],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.1016655,"threshold_uncertainty_score":0.967711,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2577454460","doi":"10.1016/j.canep.2017.01.001","title":"Development of a model to predict the 10-year cumulative risk of second primary cancer among cancer survivors","year":2017,"lang":"en","type":"article","venue":"Cancer Epidemiology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Institute of Cancer Research; Institut pour la Recherche en Santé Publique; Institut de Veille Sanitaire; Institut National Du Cancer","keywords":"Medicine; Cumulative incidence; Cancer; Poisson regression; Population; Breast cancer; Cancer registry; Prostate cancer; Cohort; Internal medicine; Colorectal cancer; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.1124488748173987,"gpt":0.3868792396187118,"spread":0.2744303648013131,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00162162,0.0003163469,0.001368231,0.0001133015,0.0003042857,0.000005135897,0.0005577778,0.000230599,0.002500461],"category_scores_gemma":[0.0007542495,0.0002200876,0.0002212504,0.00009949616,0.0007671795,0.0001439753,0.0002608405,0.000421981,0.000007001056],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006547552,"about_ca_system_score_gemma":0.002293728,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01266485,"about_ca_topic_score_gemma":0.03023077,"domain_scores_codex":[0.9972543,0.0002611071,0.001100566,0.0005893364,0.0002347,0.0005600086],"domain_scores_gemma":[0.996456,0.0006221082,0.001302008,0.001016239,0.0003393934,0.0002642584],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001209176,0.0000484276,0.9336794,0.0004467875,0.0009433616,0.000002000875,0.004124665,0.01591236,0.002038391,0.00008751616,0.01409983,0.02740806],"study_design_scores_gemma":[0.001624857,0.0001015447,0.9465154,0.0003603862,0.0002486099,8.239994e-7,0.0001459922,0.009303379,0.00282159,0.0001429695,0.03848058,0.0002538398],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9865705,0.003448334,0.0007551364,0.00217754,0.000684917,0.0009135411,0.0008039056,0.00002355037,0.004622546],"genre_scores_gemma":[0.9799594,0.002607832,0.005558689,0.003717987,0.0003679011,0.0009595929,0.00004790377,0.00006343847,0.006717237],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02715422,"threshold_uncertainty_score":0.9984114,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2127646700","doi":"10.1007/978-3-319-12505-3_24","title":"Second Malignancy Risk After Treatment of Hodgkin Lymphoma","year":2014,"lang":"en","type":"book-chapter","venue":"Hematologic malignancies","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Cancer; Internal medicine; Malignancy; Lung cancer; Oncology; Relative risk; Population; Absolute risk reduction; Radiation therapy","retraction":null,"screen_n_in":null,"score":{"opus":0.01940116088779189,"gpt":0.2364509846356947,"spread":0.2170498237479028,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001482968,0.0008368187,0.002275123,0.0002888169,0.00007978664,0.00001738444,0.0001628267,0.0007540936,0.01609021],"category_scores_gemma":[0.00004038171,0.0006333503,0.0008251232,0.00004590888,0.0004001847,0.00004770734,0.00007347845,0.0001582569,0.000344944],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003326569,"about_ca_system_score_gemma":0.0004085306,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003199756,"about_ca_topic_score_gemma":0.00007262198,"domain_scores_codex":[0.9971936,0.0000494429,0.001021523,0.0008054749,0.0004208219,0.0005091248],"domain_scores_gemma":[0.9974396,0.0001962043,0.0008395495,0.001109563,0.000189825,0.0002252885],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01236056,0.002523359,0.07949721,0.03015176,0.01134035,0.01791572,0.006928636,0.000009762275,0.004853229,0.3867769,0.1206765,0.326966],"study_design_scores_gemma":[0.004285212,0.002477501,0.005496393,0.001386725,0.001112911,0.001060825,0.00005028182,0.00001520207,0.007545707,0.00453376,0.9710991,0.0009363891],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.09546359,0.03104096,0.000130867,0.0001611125,0.0006398554,0.001659283,0.001081653,0.0002194431,0.8696032],"genre_scores_gemma":[0.276491,0.007248392,0.001323652,0.0007282478,0.0002892639,0.0002204711,0.0002695102,0.0001482366,0.7132812],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.8504226,"threshold_uncertainty_score":0.9996118,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4405364934","doi":"10.1016/j.msard.2024.106114","title":"153. Efficacy and Safety of Tolebrutinib Versus Placebo in Non-Relapsing Secondary Progressive Multiple Sclerosis: Results From the Phase 3 HERCULES Trial","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Medicine; Placebo; Relapsing remitting; Internal medicine; Pathology; Immunology; Alternative medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03891098586633257,"gpt":0.2788187953834719,"spread":0.2399078095171393,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006507599,0.0004464928,0.0007485379,0.0002050856,0.0002937129,0.0001120196,0.0001723246,0.0004008504,0.0001714781],"category_scores_gemma":[0.0007248787,0.0003240313,0.0002270864,0.0005087633,0.0005980095,0.0002791408,0.0001431307,0.0009407832,0.000008784837],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001154683,"about_ca_system_score_gemma":0.0002616915,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001271475,"about_ca_topic_score_gemma":0.0005587736,"domain_scores_codex":[0.996892,0.0002056634,0.001134617,0.0009139643,0.000356285,0.0004974694],"domain_scores_gemma":[0.9964706,0.00253861,0.0002453809,0.0004678232,0.00005701794,0.0002205535],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.371079,0.001118352,0.002665923,0.000279444,0.001248619,0.00004389282,0.01386654,0.0003024188,0.01474262,0.0000229951,0.001830066,0.5928001],"study_design_scores_gemma":[0.8213441,0.002544723,0.1126595,0.006176502,0.0007306149,0.00001050872,0.006372939,0.04254439,0.001336077,0.00004911569,0.005398771,0.0008327758],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9693099,0.02305426,0.00001695668,0.001706084,0.001208516,0.002639126,0.0005814483,0.0001018778,0.001381866],"genre_scores_gemma":[0.9896395,0.009095225,0.0003193617,0.0001353065,0.0001261809,0.00009230773,0.000450757,0.00006664058,0.00007468128],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5919673,"threshold_uncertainty_score":0.9999212,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}